155 related articles for article (PubMed ID: 32895373)
1. Combined inhibition of JAK1/2 and DNMT1 by newly identified small-molecule compounds synergistically suppresses the survival and proliferation of cervical cancer cells.
She S; Zhao Y; Kang B; Chen C; Chen X; Zhang X; Chen W; Dan S; Wang H; Wang YJ; Zhao J
Cell Death Dis; 2020 Sep; 11(9):724. PubMed ID: 32895373
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severity.
Liu PC; Caulder E; Li J; Waeltz P; Margulis A; Wynn R; Becker-Pasha M; Li Y; Crowgey E; Hollis G; Haley P; Sparks RB; Combs AP; Rodgers JD; Burn TC; Vaddi K; Fridman JS
Clin Cancer Res; 2009 Nov; 15(22):6891-900. PubMed ID: 19887489
[TBL] [Abstract][Full Text] [Related]
3. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
[TBL] [Abstract][Full Text] [Related]
4. DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A.
Hu Y; Wu F; Liu Y; Zhao Q; Tang H
Clin Epigenetics; 2019 Dec; 11(1):186. PubMed ID: 31810492
[TBL] [Abstract][Full Text] [Related]
5. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
Lopez TV; Lappin TR; Maxwell P; Shi Z; Lopez-Marure R; Aguilar C; Rocha-Zavaleta L
Int J Cancer; 2011 Dec; 129(11):2566-76. PubMed ID: 21442620
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent inhibitors of DNA methyltransferase 1 (DNMT1) through a pharmacophore-based virtual screening approach.
Krishna S; Shukla S; Lakra AD; Meeran SM; Siddiqi MI
J Mol Graph Model; 2017 Aug; 75():174-188. PubMed ID: 28582695
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore and docking-based virtual screening approach for the design of new dual inhibitors of Janus kinase 1 and Janus kinase 2.
Jasuja H; Chadha N; Kaur M; Silakari O
SAR QSAR Environ Res; 2014; 25(8):617-36. PubMed ID: 25148044
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966
[TBL] [Abstract][Full Text] [Related]
9. LncRNATCF7 up-regulates DNMT1 mediated by HPV-18 E6 and regulates biological behavior of cervical cancer cells by inhibiting miR-155.
Chen YZ; Wang JW; Meng FC; Yang P; Zhang XG; Wu HZ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8779-8787. PubMed ID: 31696464
[TBL] [Abstract][Full Text] [Related]
10. Ensemble docking-based virtual screening yields novel spirocyclic JAK1 inhibitors.
Bajusz D; Ferenczy GG; Keserű GM
J Mol Graph Model; 2016 Nov; 70():275-283. PubMed ID: 27771575
[TBL] [Abstract][Full Text] [Related]
11. Amorfrutin A inhibits TNF-α induced JAK/STAT signaling, cell survival and proliferation of human cancer cells.
Mi C; Ma J; Wang KS; Wang Z; Li MY; Li JB; Li X; Piao LX; Xu GH; Jin X
Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):338-347. PubMed ID: 28879797
[TBL] [Abstract][Full Text] [Related]
12. Loss of JAK1 Drives Innate Immune Deficiency.
Witalisz-Siepracka A; Klein K; Prinz D; Leidenfrost N; Schabbauer G; Dohnal A; Sexl V
Front Immunol; 2018; 9():3108. PubMed ID: 30671064
[TBL] [Abstract][Full Text] [Related]
13. Janus kinase JAK1 maintains the ovarian reserve of primordial follicles in the mouse ovary.
Sutherland JM; Frost ER; Ford EA; Peters AE; Reed NL; Seldon AN; Mihalas BP; Russel DL; Dunning KR; McLaughlin EA
Mol Hum Reprod; 2018 Nov; 24(11):533-542. PubMed ID: 30247637
[TBL] [Abstract][Full Text] [Related]
14. LINP1 promotes the progression of cervical cancer by scaffolding EZH2, LSD1, and DNMT1 to inhibit the expression of KLF2 and PRSS8.
Wu L; Gong Y; Yan T; Zhang H
Biochem Cell Biol; 2020 Oct; 98(5):591-599. PubMed ID: 32348690
[TBL] [Abstract][Full Text] [Related]
15. Discovery of triazolo [1,5-a] pyridine derivatives as novel JAK1/2 inhibitors.
Lu K; Wu W; Zhang C; Liu Z; Xiao B; Yuan Z; Li A; Chen D; Zhai X; Jiang Y
Bioorg Med Chem Lett; 2020 Jul; 30(14):127225. PubMed ID: 32527540
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor-based affinity probes for the investigation of JAK signaling pathways.
Höfener M; Pachl F; Kuster B; Sewald N
Proteomics; 2015 Sep; 15(17):3066-74. PubMed ID: 25959371
[TBL] [Abstract][Full Text] [Related]
17. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitors.
Labadie S; Barrett K; Blair WS; Chang C; Deshmukh G; Eigenbrot C; Gibbons P; Johnson A; Kenny JR; Kohli PB; Liimatta M; Lupardus PJ; Shia S; Steffek M; Ubhayakar S; van Abbema A; Zak M
Bioorg Med Chem Lett; 2013 Nov; 23(21):5923-30. PubMed ID: 24042009
[TBL] [Abstract][Full Text] [Related]
19. The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib.
Zheng F; Zhao Y; Li X; Tang Q; Wu J; Wu W; Hann SS
J Ethnopharmacol; 2019 Jul; 239():111928. PubMed ID: 31077779
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo characterization of SGI-1252, a small molecule inhibitor of JAK2.
Ahmed KB; Warner SL; Chen A; Gourley ES; Liu X; Vankayalapati H; Nussenzveig R; Prchal JT; Bearss DJ; Parker CJ
Exp Hematol; 2011 Jan; 39(1):14-25. PubMed ID: 20934482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
